These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of severe regurgitation of stentless aortic valve prosthesis with a self-expandable biological valve. Ussia GP; Barbanti M; Tamburino C J Invasive Cardiol; 2009 Mar; 21(3):E51-4. PubMed ID: 19258652 [TBL] [Abstract][Full Text] [Related]
7. The role of pannus in the longevity of an Ionescu-Shiley pericardial bioprosthesis. Butany JW; Kesarwani R; Yau TM; Singh G; Thangaroopan M; Nair V; Leong SW J Card Surg; 2006; 21(5):505-7. PubMed ID: 16948773 [TBL] [Abstract][Full Text] [Related]
8. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. Lund O; Bland M J Thorac Cardiovasc Surg; 2006 Jul; 132(1):20-6. PubMed ID: 16798297 [TBL] [Abstract][Full Text] [Related]
9. [Aortic valve stenosis: from valvuloplasty to percutaneous heart valve]. Sack S; Kahlert P; Khandanpour S; Kordish I; Budeus M; Naber C; Philipp S; Möhlenkamp S; Erbel R Herz; 2006 Oct; 31(7):688-93. PubMed ID: 17072784 [TBL] [Abstract][Full Text] [Related]
10. Double-balloon valvuloplasty of calcified bioprosthetic pulmonary valve twenty-three years after implantation. El Sayed MH; Darwazah AK; El Sayed HM J Heart Valve Dis; 2013 Mar; 22(2):265-9. PubMed ID: 23798220 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of percutaneous angioplasty of restenoses of coarctation and stenosis of bioprostheses in children]. Jocteur-Monrozier D; Bozio A; Clermont A; Joulié V; Maret H; Sassolas F; Senellart F; Normand J Pediatrie; 1991; 46(3):245-9. PubMed ID: 1649437 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement. Sjögren J; Gudbjartsson T; Thulin LI J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900 [TBL] [Abstract][Full Text] [Related]
13. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes? Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous and surgical treatment of aortic stenosis. Andrus BW; O'Rourke DJ Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):203-9. PubMed ID: 16509816 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis. Le Tourneau T; Marechaux S; Vincentelli A; Ennezat PV; Modine T; Polge AS; Fayad G; Prat A; Warembourg H; Deklunder G J Heart Valve Dis; 2007 Sep; 16(5):483-8. PubMed ID: 17944119 [TBL] [Abstract][Full Text] [Related]
16. Delayed improvement in valve hemodynamic performance after percutaneous pulmonary valve implantation. Rodés-Cabau J; Houde C; Perron J; Benson LN; Pibarot P Ann Thorac Surg; 2008 May; 85(5):1787-8. PubMed ID: 18442588 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous implantation of an Edwards SAPIEN valve in a failing pulmonary bioprosthesis in palliated tetralogy of Fallot. MacDonald ST; Carminati M; Butera G Eur Heart J; 2011 Jun; 32(12):1534. PubMed ID: 21273203 [No Abstract] [Full Text] [Related]